John Ackerman
Director · Guardian Pharmacy Services, Inc.
- 2024
- Sep 28, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John Ackerman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Thomas J. Salentine Jr. - $105.99M in GRDN purchases and sales in the last 12 months
- Bindley Capital Partners I, LLC - $105.99M in GRDN purchases and sales in the last 12 months
- William E. Bindley - $105.99M in GRDN purchases and sales in the last 12 months
- Pharmacy Investors, LLC - $24.57M in GRDN purchases and sales in the last 12 months
- Fred Burke - $19.93M in GRDN purchases and sales in the last 12 months
- Kendall Forbes - $10.29M in GRDN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John Ackerman?
John Ackerman is a corporate insider, tracked as Director of Guardian Pharmacy Services, Inc. (GRDN). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John Ackerman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has John Ackerman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($32.75M) across all tracked filings.